PubMed:27149136
Annnotations
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-27 | Sentence | denotes | Paraneoplastic Scleroderma: |
TextSentencer_T2 | 28-48 | Sentence | denotes | Are There Any Clues? |
TextSentencer_T3 | 49-152 | Sentence | denotes | Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
TextSentencer_T4 | 153-234 | Sentence | denotes | We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
TextSentencer_T5 | 235-328 | Sentence | denotes | Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
TextSentencer_T6 | 329-473 | Sentence | denotes | The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
TextSentencer_T7 | 474-736 | Sentence | denotes | In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
TextSentencer_T8 | 737-950 | Sentence | denotes | Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
TextSentencer_T9 | 951-1043 | Sentence | denotes | Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
TextSentencer_T10 | 1044-1110 | Sentence | denotes | Tumorous cells further induce cytotoxic and autoantibody response. |
TextSentencer_T11 | 1111-1259 | Sentence | denotes | Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
TextSentencer_T12 | 1260-1547 | Sentence | denotes | Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
TextSentencer_T13 | 1548-1602 | Sentence | denotes | This factor is also produced by lung cancer cells (4). |
TextSentencer_T14 | 1603-1681 | Sentence | denotes | The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
TextSentencer_T15 | 1682-1756 | Sentence | denotes | Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
TextSentencer_T16 | 1757-1813 | Sentence | denotes | The histological picture is consistent with scleroderma. |
TextSentencer_T17 | 1814-1961 | Sentence | denotes | Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
TextSentencer_T18 | 1962-2021 | Sentence | denotes | Our patients did not fulfill enough of the criteria for SS. |
TextSentencer_T19 | 2022-2134 | Sentence | denotes | Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
TextSentencer_T20 | 2135-2256 | Sentence | denotes | All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
TextSentencer_T21 | 2257-2391 | Sentence | denotes | A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
TextSentencer_T22 | 2392-2451 | Sentence | denotes | The skin on her breasts and cheeks was diffusely indurated. |
TextSentencer_T23 | 2452-2731 | Sentence | denotes | Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
TextSentencer_T24 | 2732-2800 | Sentence | denotes | She was given prednisone 40 mg/day but did not return for follow up. |
TextSentencer_T25 | 2801-2916 | Sentence | denotes | After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
TextSentencer_T26 | 2917-2992 | Sentence | denotes | A 74-year-old woman had localized scleroderma on the trunk for three years. |
TextSentencer_T27 | 2993-3090 | Sentence | denotes | She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
TextSentencer_T28 | 3091-3288 | Sentence | denotes | Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
TextSentencer_T29 | 3289-3329 | Sentence | denotes | Examination revealed endometrial cancer. |
TextSentencer_T30 | 3330-3419 | Sentence | denotes | The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
TextSentencer_T31 | 3420-3525 | Sentence | denotes | Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
TextSentencer_T32 | 3526-3697 | Sentence | denotes | A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
TextSentencer_T33 | 3698-3824 | Sentence | denotes | Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
TextSentencer_T34 | 3825-3978 | Sentence | denotes | Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
TextSentencer_T35 | 3979-4125 | Sentence | denotes | A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
TextSentencer_T36 | 4126-4291 | Sentence | denotes | Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
TextSentencer_T37 | 4292-4357 | Sentence | denotes | She was given prednisone 40 mg/day and penicillamine with effect. |
TextSentencer_T38 | 4358-4477 | Sentence | denotes | In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
TextSentencer_T39 | 4478-4522 | Sentence | denotes | She is monitored for her suprarenal adenoma. |
TextSentencer_T40 | 4523-4742 | Sentence | denotes | Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
TextSentencer_T41 | 4743-4837 | Sentence | denotes | Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
TextSentencer_T42 | 4838-5042 | Sentence | denotes | One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
TextSentencer_T43 | 5043-5192 | Sentence | denotes | Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
TextSentencer_T44 | 5193-5311 | Sentence | denotes | Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
TextSentencer_T45 | 5312-5386 | Sentence | denotes | Such studies may confirm the true link between scleroderma and malignancy. |
TextSentencer_T46 | 5387-5544 | Sentence | denotes | These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
TextSentencer_T47 | 5545-5611 | Sentence | denotes | In the case of a successful tumor treatment, skin changes regress. |
T1 | 0-27 | Sentence | denotes | Paraneoplastic Scleroderma: |
T2 | 28-48 | Sentence | denotes | Are There Any Clues? |
T3 | 49-152 | Sentence | denotes | Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
T4 | 153-234 | Sentence | denotes | We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
T5 | 235-328 | Sentence | denotes | Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
T6 | 329-473 | Sentence | denotes | The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
T7 | 474-736 | Sentence | denotes | In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
T8 | 737-950 | Sentence | denotes | Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
T9 | 951-1043 | Sentence | denotes | Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
T10 | 1044-1110 | Sentence | denotes | Tumorous cells further induce cytotoxic and autoantibody response. |
T11 | 1111-1259 | Sentence | denotes | Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
T12 | 1260-1547 | Sentence | denotes | Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
T13 | 1548-1602 | Sentence | denotes | This factor is also produced by lung cancer cells (4). |
T14 | 1603-1681 | Sentence | denotes | The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
T15 | 1682-1756 | Sentence | denotes | Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
T16 | 1757-1813 | Sentence | denotes | The histological picture is consistent with scleroderma. |
T17 | 1814-1961 | Sentence | denotes | Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
T18 | 1962-2021 | Sentence | denotes | Our patients did not fulfill enough of the criteria for SS. |
T19 | 2022-2134 | Sentence | denotes | Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
T20 | 2135-2256 | Sentence | denotes | All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
T21 | 2257-2391 | Sentence | denotes | A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
T22 | 2392-2451 | Sentence | denotes | The skin on her breasts and cheeks was diffusely indurated. |
T23 | 2452-2731 | Sentence | denotes | Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
T24 | 2732-2800 | Sentence | denotes | She was given prednisone 40 mg/day but did not return for follow up. |
T25 | 2801-2916 | Sentence | denotes | After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
T26 | 2917-2992 | Sentence | denotes | A 74-year-old woman had localized scleroderma on the trunk for three years. |
T27 | 2993-3090 | Sentence | denotes | She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
T28 | 3091-3288 | Sentence | denotes | Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
T29 | 3289-3329 | Sentence | denotes | Examination revealed endometrial cancer. |
T30 | 3330-3419 | Sentence | denotes | The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
T31 | 3420-3525 | Sentence | denotes | Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
T32 | 3526-3697 | Sentence | denotes | A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
T33 | 3698-3824 | Sentence | denotes | Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
T34 | 3825-3978 | Sentence | denotes | Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
T35 | 3979-4125 | Sentence | denotes | A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
T36 | 4126-4291 | Sentence | denotes | Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
T37 | 4292-4357 | Sentence | denotes | She was given prednisone 40 mg/day and penicillamine with effect. |
T38 | 4358-4477 | Sentence | denotes | In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
T39 | 4478-4522 | Sentence | denotes | She is monitored for her suprarenal adenoma. |
T40 | 4523-4742 | Sentence | denotes | Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
T41 | 4743-4837 | Sentence | denotes | Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
T42 | 4838-5042 | Sentence | denotes | One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
T43 | 5043-5192 | Sentence | denotes | Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
T44 | 5193-5311 | Sentence | denotes | Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
T45 | 5312-5386 | Sentence | denotes | Such studies may confirm the true link between scleroderma and malignancy. |
T46 | 5387-5544 | Sentence | denotes | These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
T47 | 5545-5611 | Sentence | denotes | In the case of a successful tumor treatment, skin changes regress. |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-27 | Sentence | denotes | Paraneoplastic Scleroderma: |
T2 | 28-48 | Sentence | denotes | Are There Any Clues? |
T3 | 49-152 | Sentence | denotes | Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
T4 | 153-234 | Sentence | denotes | We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
T5 | 235-328 | Sentence | denotes | Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
T6 | 329-473 | Sentence | denotes | The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
T7 | 474-736 | Sentence | denotes | In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
T8 | 737-950 | Sentence | denotes | Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
T9 | 951-1043 | Sentence | denotes | Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
T10 | 1044-1110 | Sentence | denotes | Tumorous cells further induce cytotoxic and autoantibody response. |
T11 | 1111-1259 | Sentence | denotes | Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
T12 | 1260-1547 | Sentence | denotes | Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
T13 | 1548-1602 | Sentence | denotes | This factor is also produced by lung cancer cells (4). |
T14 | 1603-1681 | Sentence | denotes | The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
T15 | 1682-1756 | Sentence | denotes | Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
T16 | 1757-1813 | Sentence | denotes | The histological picture is consistent with scleroderma. |
T17 | 1814-1961 | Sentence | denotes | Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
T18 | 1962-2021 | Sentence | denotes | Our patients did not fulfill enough of the criteria for SS. |
T19 | 2022-2134 | Sentence | denotes | Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
T20 | 2135-2256 | Sentence | denotes | All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
T21 | 2257-2391 | Sentence | denotes | A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
T22 | 2392-2451 | Sentence | denotes | The skin on her breasts and cheeks was diffusely indurated. |
T23 | 2452-2731 | Sentence | denotes | Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
T24 | 2732-2800 | Sentence | denotes | She was given prednisone 40 mg/day but did not return for follow up. |
T25 | 2801-2916 | Sentence | denotes | After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
T26 | 2917-2992 | Sentence | denotes | A 74-year-old woman had localized scleroderma on the trunk for three years. |
T27 | 2993-3090 | Sentence | denotes | She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
T28 | 3091-3288 | Sentence | denotes | Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
T29 | 3289-3329 | Sentence | denotes | Examination revealed endometrial cancer. |
T30 | 3330-3419 | Sentence | denotes | The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
T31 | 3420-3525 | Sentence | denotes | Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
T32 | 3526-3697 | Sentence | denotes | A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
T33 | 3698-3824 | Sentence | denotes | Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
T34 | 3825-3978 | Sentence | denotes | Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
T35 | 3979-4125 | Sentence | denotes | A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
T36 | 4126-4291 | Sentence | denotes | Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
T37 | 4292-4357 | Sentence | denotes | She was given prednisone 40 mg/day and penicillamine with effect. |
T38 | 4358-4477 | Sentence | denotes | In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
T39 | 4478-4522 | Sentence | denotes | She is monitored for her suprarenal adenoma. |
T40 | 4523-4742 | Sentence | denotes | Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
T41 | 4743-4837 | Sentence | denotes | Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
T42 | 4838-5042 | Sentence | denotes | One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
T43 | 5043-5192 | Sentence | denotes | Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
T44 | 5193-5311 | Sentence | denotes | Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
T45 | 5312-5386 | Sentence | denotes | Such studies may confirm the true link between scleroderma and malignancy. |
T46 | 5387-5544 | Sentence | denotes | These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
T47 | 5545-5611 | Sentence | denotes | In the case of a successful tumor treatment, skin changes regress. |
T1 | 0-27 | Sentence | denotes | Paraneoplastic Scleroderma: |
T2 | 28-48 | Sentence | denotes | Are There Any Clues? |
T3 | 49-152 | Sentence | denotes | Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
T4 | 153-234 | Sentence | denotes | We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
T5 | 235-328 | Sentence | denotes | Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
T6 | 329-473 | Sentence | denotes | The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
T7 | 474-736 | Sentence | denotes | In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
T8 | 737-950 | Sentence | denotes | Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
T9 | 951-1043 | Sentence | denotes | Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
T10 | 1044-1110 | Sentence | denotes | Tumorous cells further induce cytotoxic and autoantibody response. |
T11 | 1111-1259 | Sentence | denotes | Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
T12 | 1260-1547 | Sentence | denotes | Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
T13 | 1548-1602 | Sentence | denotes | This factor is also produced by lung cancer cells (4). |
T14 | 1603-1681 | Sentence | denotes | The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
T15 | 1682-1756 | Sentence | denotes | Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
T16 | 1757-1813 | Sentence | denotes | The histological picture is consistent with scleroderma. |
T17 | 1814-1961 | Sentence | denotes | Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
T18 | 1962-2021 | Sentence | denotes | Our patients did not fulfill enough of the criteria for SS. |
T19 | 2022-2134 | Sentence | denotes | Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
T20 | 2135-2256 | Sentence | denotes | All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
T21 | 2257-2391 | Sentence | denotes | A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
T22 | 2392-2451 | Sentence | denotes | The skin on her breasts and cheeks was diffusely indurated. |
T23 | 2452-2731 | Sentence | denotes | Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
T24 | 2732-2800 | Sentence | denotes | She was given prednisone 40 mg/day but did not return for follow up. |
T25 | 2801-2916 | Sentence | denotes | After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
T26 | 2917-2992 | Sentence | denotes | A 74-year-old woman had localized scleroderma on the trunk for three years. |
T27 | 2993-3090 | Sentence | denotes | She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
T28 | 3091-3288 | Sentence | denotes | Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
T29 | 3289-3329 | Sentence | denotes | Examination revealed endometrial cancer. |
T30 | 3330-3419 | Sentence | denotes | The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
T31 | 3420-3525 | Sentence | denotes | Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
T32 | 3526-3697 | Sentence | denotes | A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
T33 | 3698-3824 | Sentence | denotes | Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
T34 | 3825-3978 | Sentence | denotes | Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
T35 | 3979-4125 | Sentence | denotes | A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
T36 | 4126-4291 | Sentence | denotes | Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
T37 | 4292-4357 | Sentence | denotes | She was given prednisone 40 mg/day and penicillamine with effect. |
T38 | 4358-4477 | Sentence | denotes | In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
T39 | 4478-4522 | Sentence | denotes | She is monitored for her suprarenal adenoma. |
T40 | 4523-4742 | Sentence | denotes | Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
T41 | 4743-4837 | Sentence | denotes | Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
T42 | 4838-5042 | Sentence | denotes | One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
T43 | 5043-5192 | Sentence | denotes | Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
T44 | 5193-5311 | Sentence | denotes | Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
T45 | 5312-5386 | Sentence | denotes | Such studies may confirm the true link between scleroderma and malignancy. |
T46 | 5387-5544 | Sentence | denotes | These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
T47 | 5545-5611 | Sentence | denotes | In the case of a successful tumor treatment, skin changes regress. |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 467-472 | http://purl.obolibrary.org/obo/UBERON_0002530 | denotes | gland |
PD-UBERON-AE-B_T2 | 798-802 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PD-UBERON-AE-B_T3 | 1580-1584 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PD-UBERON-AE-B_T4 | 874-880 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T5 | 2408-2415 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breasts |
PD-UBERON-AE-B_T6 | 882-891 | http://purl.obolibrary.org/obo/UBERON_0001043 | denotes | esophagus |
PD-UBERON-AE-B_T7 | 2652-2661 | http://purl.obolibrary.org/obo/UBERON_0001043 | denotes | esophagus |
PD-UBERON-AE-B_T8 | 893-900 | http://purl.obolibrary.org/obo/UBERON_0000945 | denotes | stomach |
PD-UBERON-AE-B_T9 | 902-913 | http://purl.obolibrary.org/obo/UBERON_0001728 | denotes | nasopharynx |
PD-UBERON-AE-B_T10 | 1291-1302 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
PD-UBERON-AE-B_T11 | 1461-1478 | http://purl.obolibrary.org/obo/UBERON_0002384 | denotes | connective tissue |
PD-UBERON-AE-B_T12 | 1472-1478 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T13 | 4751-4757 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T14 | 2346-2350 | http://purl.obolibrary.org/obo/UBERON_0000974 | denotes | neck |
PD-UBERON-AE-B_T15 | 2352-2357 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T16 | 2970-2975 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T17 | 3165-3170 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T18 | 4097-4102 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T19 | 2420-2426 | http://purl.obolibrary.org/obo/UBERON_0001567 | denotes | cheeks |
PD-UBERON-AE-B_T20 | 2725-2730 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
PD-UBERON-AE-B_T21 | 3644-3648 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PD-UBERON-AE-B_T22 | 3973-3977 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PD-UBERON-AE-B_T23 | 4426-4430 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PubCasesHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
AB1 | 62-73 | HP:0100324 | denotes | Scleroderma |
TI1 | 15-26 | HP:0100324 | denotes | Scleroderma |
AB2 | 196-207 | HP:0100324 | denotes | scleroderma |
AB3 | 377-386 | HP:0030731 | denotes | carcinoma |
AB4 | 388-409 | HP:0012114 | denotes | endometrial carcinoma |
AB5 | 500-511 | HP:0100324 | denotes | scleroderma |
AB6 | 596-607 | HP:0100324 | denotes | scleroderma |
AB7 | 666-677 | HP:0100324 | denotes | scleroderma |
AB8 | 915-923 | HP:0002861 | denotes | melanoma |
AB9 | 929-936 | HP:0100242 | denotes | sarcoma |
AB10 | 1111-1122 | HP:0100324 | denotes | Scleroderma |
AB11 | 1627-1638 | HP:0100324 | denotes | scleroderma |
AB12 | 1658-1669 | HP:0100324 | denotes | scleroderma |
AB13 | 1801-1812 | HP:0100324 | denotes | scleroderma |
AB14 | 1868-1881 | HP:0011838 | denotes | sclerodactyly |
AB15 | 1887-1905 | HP:0030880 | denotes | Raynaud phenomenon |
AB16 | 1940-1951 | HP:0100324 | denotes | scleroderma |
AB17 | 2049-2060 | HP:0100324 | denotes | scleroderma |
AB18 | 2110-2121 | HP:0100324 | denotes | scleroderma |
AB19 | 2191-2202 | HP:0100324 | denotes | scleroderma |
AB20 | 2471-2487 | HP:0001873 | denotes | thrombocytopenia |
AB21 | 2663-2681 | HP:0001433 | denotes | hepatosplenomegaly |
AB22 | 2854-2863 | HP:0030731 | denotes | carcinoma |
AB23 | 2951-2962 | HP:0100324 | denotes | scleroderma |
AB24 | 3138-3149 | HP:0100324 | denotes | scleroderma |
AB25 | 3420-3431 | HP:0100324 | denotes | Scleroderma |
AB26 | 3653-3664 | HP:0100324 | denotes | scleroderma |
AB27 | 4017-4037 | HP:0001370 | denotes | rheumatoid arthritis |
AB28 | 4147-4157 | HP:0030160 | denotes | cervicitis |
AB29 | 4232-4244 | HP:0000822 | denotes | hypertension |
AB30 | 4437-4448 | HP:0100324 | denotes | scleroderma |
AB31 | 4540-4551 | HP:0100324 | denotes | scleroderma |
AB32 | 4620-4631 | HP:0100324 | denotes | scleroderma |
AB33 | 5030-5041 | HP:0100324 | denotes | scleroderma |
AB34 | 5067-5078 | HP:0100324 | denotes | scleroderma |
AB35 | 5180-5191 | HP:0100324 | denotes | scleroderma |
AB36 | 5270-5281 | HP:0100324 | denotes | scleroderma |
AB37 | 5359-5370 | HP:0100324 | denotes | scleroderma |
AB38 | 5499-5506 | HP:0012344 | denotes | morphea |
PubCasesORDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
AB1 | 1931-1951 | ORDO:90291 | denotes | systemic scleroderma |
AB2 | 2039-2060 | ORDO:90289 | denotes | localized scleroderma |
AB3 | 2100-2121 | ORDO:90289 | denotes | localized scleroderma |
AB4 | 2941-2962 | ORDO:90289 | denotes | localized scleroderma |
AB5 | 4610-4631 | ORDO:90289 | denotes | localized scleroderma |
AB6 | 5261-5281 | ORDO:90291 | denotes | systemic scleroderma |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 798-802 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PD-UBERON-AE-B_T2 | 1580-1584 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PD-UBERON-AE-B_T3 | 893-900 | http://purl.obolibrary.org/obo/UBERON_0000945 | denotes | stomach |
PD-UBERON-AE-B_T4 | 1291-1302 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
PD-UBERON-AE-B_T5 | 874-880 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T6 | 2408-2415 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breasts |
PD-UBERON-AE-B_T7 | 1472-1478 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T8 | 4751-4757 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T9 | 3644-3648 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PD-UBERON-AE-B_T10 | 3973-3977 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PD-UBERON-AE-B_T11 | 4426-4430 | http://purl.obolibrary.org/obo/UBERON_0000978 | denotes | legs |
PD-UBERON-AE-B_T12 | 2346-2350 | http://purl.obolibrary.org/obo/UBERON_0000974 | denotes | neck |
PD-UBERON-AE-B_T13 | 467-472 | http://purl.obolibrary.org/obo/UBERON_0002530 | denotes | gland |
PD-UBERON-AE-B_T14 | 882-891 | http://purl.obolibrary.org/obo/UBERON_0001043 | denotes | esophagus |
PD-UBERON-AE-B_T15 | 2652-2661 | http://purl.obolibrary.org/obo/UBERON_0001043 | denotes | esophagus |
PD-UBERON-AE-B_T16 | 902-913 | http://purl.obolibrary.org/obo/UBERON_0001728 | denotes | nasopharynx |
PD-UBERON-AE-B_T17 | 1461-1478 | http://purl.obolibrary.org/obo/UBERON_0002384 | denotes | connective tissue |
PD-UBERON-AE-B_T18 | 2352-2357 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T19 | 2970-2975 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T20 | 3165-3170 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T21 | 4097-4102 | http://purl.obolibrary.org/obo/UBERON_0002100 | denotes | trunk |
PD-UBERON-AE-B_T22 | 2420-2426 | http://purl.obolibrary.org/obo/UBERON_0001567 | denotes | cheeks |
PD-UBERON-AE-B_T23 | 2725-2730 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
PD-UBERON-AE-B_T24 | 4743-4757 | http://purl.obolibrary.org/obo/UBERON_0018303 | denotes | Adrenal tissue |